Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best Science Apps

More »
Feb 01, 2012 (Vol. 32, No. 3)

ESmol (developer: biochem_fan)

URL:bit.ly/zlMd0u
  • Easy to maniplate molecules, different viewing options
  • No help/introduction section in app
Platform: Android Phone  
Cost: Free

ESmol is a simple, functional molecular viewer. All of the features of the app are accessed from the menu—these include display options for both the protein and its ligands, if they are present in the structure. The protein can be displayed as a trace or ribbon, and sidechains can be visible or hidden. The ligands can be depicted using lines, sticks, or spheres. One thing that is noticeably absent from this app is a help/introduction page. Users will not know, for example, that the sample molecule that appears when the app is opened is deoxyhemoglobin; nor is it clear exactly how to display other molecules. This information is more clearly explained on the app page in the Android Market. Users can open pdb files that have been saved to the SD card in a certain directory, or pdb files can be directly downloaded from the RCSB Protein Data Bank.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »